Back
Alimera Sciences Vs. Reneo Pharmaceuticals Industry Stock Comparison
Buy
61
ALIM
Alimera Sciences
Last Price:
5.54
Seasonality Move:
-13.1%
Sell
23
RPHM
Reneo Pharmaceuticals
Last Price:
1.50
Seasonality Move:
-26.13%
Buy
61
Alimera Sciences (ALIM)
is a Buy
Is Alimera Sciences a Buy, Sell or Hold?
- The current Alimera Sciences [ALIM] share price is $5.54. The Score for ALIM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- ALIM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Reneo Pharmaceuticals (RPHM)
is a Sell
Is Reneo Pharmaceuticals a Buy, Sell or Hold?
- The current Reneo Pharmaceuticals [RPHM] share price is $1.50. The Score for RPHM is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- RPHM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALIM Stock Price Chart
What is Alimera Sciences's stock price today?
-
The Alimera Sciences share price today is $5.54
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALIM is experiencing slight buying pressure.
RPHM Stock Price Chart
What is Reneo Pharmaceuticals's stock price today?
-
The Reneo Pharmaceuticals share price today is $1.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RPHM is experiencing slight buying pressure.
ALIM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 52.49 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.47 - 5.63) | Sell |
Bollinger Bands (100): | (3.51 - 5.79) | Buy |
RPHM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 55.1 | Buy |
Chaikin Money Flow: | 264572 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.4 - 1.56) | Buy |
Bollinger Bands (100): | (1.44 - 1.7) | Sell |
ALIM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.5 | Buy |
20-day SMA: | 5.54 | Buy |
50-day SMA: | 5.56 | Sell |
200-day SMA: | 4.21 | Buy |
8-day EMA: | 5.52 | Buy |
20-day EMA: | 5.53 | Buy |
50-day EMA: | 5.35 | Buy |
200-day EMA: | 4.41 | Buy |
RPHM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.41 | Buy |
20-day SMA: | 1.47 | Buy |
50-day SMA: | 1.47 | Buy |
200-day SMA: | 1.85 | Sell |
8-day EMA: | 1.42 | Buy |
20-day EMA: | 1.44 | Buy |
50-day EMA: | 1.48 | Buy |
200-day EMA: | 2.31 | Sell |
Alimera Sciences Earnings Growth & ALIM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.02 per share, an increase this year of $0.30 per share, and an increase next year of $0.17 per share.
Reneo Pharmaceuticals Earnings Growth & RPHM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and a decrease next year of $0.04 per share.
Alimera Sciences Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Reneo Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |